Close
Nordic 9Nordic 9

Odimma Therapeutics (private company)

France odimma-therapeutics.com
See something wrong or missing? Let us know
Offices:Strasbourg
Industry:BiotechHealth services
Business model:B2B

Odimma is a biotech company from France that focuses on precision medicine and cure for personalized cancer immunotherapy.

Investors: we tracked 4 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 2.2M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Odimma Therapeutics

Name Criteria
Finland FinnAdvance
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom iLoF
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Novai
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Poland Molecule.one
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France PEP-Therapy
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Nanolyze
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Clustermarket
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Sequential Skin
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Exogene
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Spirea
60%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 1
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top